240 related articles for article (PubMed ID: 24120911)
1. Impaired bile acid handling and aggravated liver injury in mice expressing a hepatocyte-specific RXRα variant lacking the DNA-binding domain.
Kosters A; Felix JC; Desai MS; Karpen SJ
J Hepatol; 2014 Feb; 60(2):362-9. PubMed ID: 24120911
[TBL] [Abstract][Full Text] [Related]
2. Gene-specific alterations of hepatic gene expression by ligand activation or hepatocyte-selective inhibition of retinoid X receptor-α signalling during inflammation.
Kosters A; Tian F; Wan YJ; Karpen SJ
Liver Int; 2012 Feb; 32(2):321-30. PubMed ID: 22098603
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of resistance of hepatocyte retinoid X receptor alpha-null mice to WY-14,643-induced hepatocyte proliferation and cholestasis.
Gyamfi MA; Wan YJ
J Biol Chem; 2009 Apr; 284(14):9321-30. PubMed ID: 19176532
[TBL] [Abstract][Full Text] [Related]
4. Maternal obesogenic diet enhances cholestatic liver disease in offspring.
Thompson MD; Hinrichs H; Faerber A; Tarr PI; Davidson NO
J Lipid Res; 2022 May; 63(5):100205. PubMed ID: 35341737
[TBL] [Abstract][Full Text] [Related]
5. Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice.
Gyamfi MA; Tanaka Y; He L; Klaassen CD; Wan YJ
Toxicol Appl Pharmacol; 2009 Jan; 234(2):166-78. PubMed ID: 18952117
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte retinoid X receptor alpha-dependent regulation of lipid homeostasis and inflammatory cytokine expression contributes to alcohol-induced liver injury.
Gyamfi MA; He L; French SW; Damjanov I; Wan YJ
J Pharmacol Exp Ther; 2008 Feb; 324(2):443-53. PubMed ID: 17975011
[TBL] [Abstract][Full Text] [Related]
7. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
[TBL] [Abstract][Full Text] [Related]
8. Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression.
Vanwijngaerden YM; Wauters J; Langouche L; Vander Perre S; Liddle C; Coulter S; Vanderborght S; Roskams T; Wilmer A; Van den Berghe G; Mesotten D
Hepatology; 2011 Nov; 54(5):1741-52. PubMed ID: 21800341
[TBL] [Abstract][Full Text] [Related]
9. Metabolic preconditioning protects BSEP/ABCB11
Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M
J Hepatol; 2017 Jan; 66(1):95-101. PubMed ID: 27593105
[TBL] [Abstract][Full Text] [Related]
10. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
Hoeke MO; Plass JR; Heegsma J; Geuken M; van Rijsbergen D; Baller JF; Kuipers F; Moshage H; Jansen PL; Faber KN
Hepatology; 2009 Jan; 49(1):151-9. PubMed ID: 19111018
[TBL] [Abstract][Full Text] [Related]
11. Role of farnesoid X receptor in the enhancement of canalicular bile acid output and excretion of unconjugated bile acids: a mechanism for protection against cholic acid-induced liver toxicity.
Miyata M; Tozawa A; Otsuka H; Nakamura T; Nagata K; Gonzalez FJ; Yamazoe Y
J Pharmacol Exp Ther; 2005 Feb; 312(2):759-66. PubMed ID: 15466244
[TBL] [Abstract][Full Text] [Related]
12. Melatonin improves cholestatic liver disease via the gut-liver axis.
Liu X; Li J; Shi M; Fu J; Wang Y; Kang W; Liu J; Zhu F; Huang K; Chen X; Liu Y
J Pineal Res; 2024 Jan; 76(1):e12929. PubMed ID: 38047407
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice.
Li WK; Wang GF; Wang TM; Li YY; Li YF; Lu XY; Wang YH; Zhang H; Liu P; Wu JS; Ma YM
Phytomedicine; 2019 Sep; 62():152948. PubMed ID: 31129431
[TBL] [Abstract][Full Text] [Related]
14. Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis.
Tardelli M; Bruschi FV; Fuchs CD; Claudel T; Auer N; Kunczer V; Baumgartner M; A H O Ronda O; Verkade HJ; Stojakovic T; Scharnagl H; Habib A; Zimmermann R; Lotersztajn S; Trauner M
Hepatology; 2020 May; 71(5):1750-1765. PubMed ID: 31505038
[TBL] [Abstract][Full Text] [Related]
15. Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.
Chen Y; Guldiken N; Spurny M; Mohammed HH; Haybaeck J; Pollheimer MJ; Fickert P; Gassler N; Jeon MK; Trautwein C; Strnad P
J Pathol; 2015 Nov; 237(3):343-54. PubMed ID: 26108453
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis.
Desai MS; Eblimit Z; Thevananther S; Kosters A; Moore DD; Penny DJ; Karpen SJ
Liver Int; 2015 Apr; 35(4):1464-77. PubMed ID: 24330504
[TBL] [Abstract][Full Text] [Related]
17. Bile acid-induced Mallory body formation in drug-primed mouse liver.
Fickert P; Trauner M; Fuchsbichler A; Stumptner C; Zatloukal K; Denk H
Am J Pathol; 2002 Dec; 161(6):2019-26. PubMed ID: 12466118
[TBL] [Abstract][Full Text] [Related]
18. Impact of parenteral nutrition versus fasting on hepatic bile acid production and transport in a rabbit model of prolonged critical illness.
Vanwijngaerden YM; Langouche L; Derde S; Liddle C; Coulter S; van den Berghe G; Mesotten D
Shock; 2014 Jan; 41(1):48-54. PubMed ID: 24089008
[TBL] [Abstract][Full Text] [Related]
19. Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha.
Kosters A; White DD; Sun H; Thevananther S; Karpen SJ
J Hepatol; 2009 Nov; 51(5):898-908. PubMed ID: 19767119
[TBL] [Abstract][Full Text] [Related]
20. Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor.
Zhang L; Shi J; Shen Q; Fu Y; Qi S; Wu J; Chen J; Zhang H; Mu Y; Chen G; Liu P; Liu W
J Ethnopharmacol; 2024 Jan; 318(Pt A):116833. PubMed ID: 37400008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
